炎性受体NOD2及NF-κB在痛风性关节炎中的研究进展
Progress of the Inflammatory Receptor NOD2 and NF-κB in Gouty Arthritis
DOI: 10.12677/ACM.2023.1371582, PDF,   
作者: 陈 凤, 苏 娟*：青海大学附属医院风湿免疫科，青海 西宁
关键词: 炎性受体NOD2；NF-κB；痛风性关节炎；Inflammatory Receptor NOD2； NF-κB； Gouty Arthritis
摘要: 痛风是最常见的晶体诱导的自身炎症性关节疾病，当高尿酸血症、血清尿酸盐持续升高导致自身组织中的尿酸盐水平过饱和，导致单钠尿酸盐(monosodium urate, MSU)晶体在关节内和关节周围形成和沉积时就会发生痛风。研究发现，MSU通过激活炎性受体NOD2通路，进而激活NF-κB炎症因子，参与痛风性关节炎的发作。本文就炎性受体NOD2及NF-κB参与痛风性关节炎的过程研究进展综述如下。
Abstract: Gout is the most common crystal-induced autoinflammatory joint disease, which occurs when hyperuricemia and sustained elevation of serum urate lead to oversaturation of urate levels in the own tissues, leading to the formation and deposition of monosodium urate, monosodium urate (MSU) crystals in and around the joints. We found that MSU is involved in the onset of gouty arthritis by activating the inflammatory receptor NOD2 pathway and then activating NF-κB inflammatory fac-tors. This review summarizes the involvement of the inflammatory receptor NOD2 and NF-κB in gouty arthritis.
文章引用：陈凤, 苏娟. 炎性受体NOD2及NF-κB在痛风性关节炎中的研究进展[J]. 临床医学进展, 2023, 13(7): 11324-11328. https://doi.org/10.12677/ACM.2023.1371582

参考文献

[1] Dehlin, M., Jacobsson, L. and Roddy, E. (2020) Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors. Nature Reviews Rheumatology, 16, 380-390. [Google Scholar] [CrossRef] [PubMed]
[2] 蔺娜, 徐丽萍, 宋欣伟. 痛风性关节炎血清炎症因子水平与骨代谢标志物变化分析[J]. 风湿病与关节炎, 2021, 10(11): 17-19, 42.
[3] 潘显阳, 陶金辉, 李向培. 痛风性关节炎发病的炎性机制研究进展[J]. 安徽医科大学学报, 2021, 56(7): 1167-1171.
[4] 高千惠. 痛风临床特征变化及发病年轻化相关因素研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2021.
[5] Singh, J.A. and Gaffo, A. (2020) Gout Epidemiology and Comorbidities. Seminars in Arthritis and Rheumatism, 50, S11-S16. [Google Scholar] [CrossRef] [PubMed]
[6] 杨丽华, 刘晓丽, 蒋雅琼, 等. 我国痛风的患病率及危险因素[J]. 医学研究杂志, 2019, 48(12): 4-6, 10.
[7] Galozzi, P., Bindoli, S., Doria, A., Oliviero, F. and Sfriso, P. (2021) Autoinflammatory Features in Gouty Arthritis. Journal of Clinical Medicine, 10, Article 1880. [Google Scholar] [CrossRef] [PubMed]
[8] Maekawa, S., Ohto, U., Shibata, T., Miyake, K. and Shimizu, T. (2016) Crystal Structure of NOD2 and Its Implications in Human Disease. Nature Communications, 7, Arti-cle No. 11813. [Google Scholar] [CrossRef] [PubMed]
[9] Heim, V.J., Stafford, C.A. and Nachbur, U. (2019) NOD Signaling and Cell Death. Frontiers in Cell and Developmental Biology, 7, Article 208. [Google Scholar] [CrossRef] [PubMed]
[10] Harada, M., Van Wagoner, D.R. and Nattel, S. (2015) Role of In-flammation in Atrial Fibrillation Pathophysiology and Management. Circulation Journal, 79, 495-502. [Google Scholar] [CrossRef] 
[11] Johansson, M.E., Zhang, X.Y., Edfeldt, K., et al. (2014) Innate Im-mune Receptor NOD2 Promotes Vascular Inflammation and Formation of Lipid-Rich Necrotic Cores in Hypercholester-olemic Mice. European Journal of Immunology, 44, 3081-3092. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, H.Q., Zhang, X.Y., Edfeldt, K., et al. (2013) NOD2-Mediated Innate Immune Signaling Regulates the Eicosanoids in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 2193-2201. [Google Scholar] [CrossRef] 
[13] Jati, G.A.K., Assihhah, N., Wati, A.A. and Salasia, S.I.O. (2022) Immunosuppression by Piperine as a Regulator of the NLRP3 Inflammasome through MAPK/NF-κB in Mono-sodium Urate-Induced Rat Gouty Arthritis. Veterinary World, 15, 288-298. [Google Scholar] [CrossRef] [PubMed]
[14] Kuo, C.F., Grainge, M.J., Zhang, W.Y. and Doherty, M. (2015) Global Epidemiology of Gout: Prevalence, Incidence and Risk Factors. Nature Reviews Rheumatology, 11, 649-662. [Google Scholar] [CrossRef] [PubMed]
[15] Miller, Y.I., Choi, S.H., Wiesner, P., et al. (2011) Oxida-tion-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity. Circulation Research, 108, 235-248. [Google Scholar] [CrossRef] 
[16] Fukami, K., Yamagishi, S. and Okuda, S. (2014) Role of AGEs-RAGE System in Cardiovascular Disease. Current Pharmaceutical Design, 20, 2395-2402. [Google Scholar] [CrossRef] [PubMed]
[17] Brown, K.D., Claudio, E. and Siebenlist, U. (2008) The Roles of the Classical and Alternative Nuclear Factor-κB Pathways: Potential Implications for Autoimmunity and Rheu-matoid Arthritis. Arthritis Research & Therapy, 10, Article No. 212. [Google Scholar] [CrossRef] [PubMed]
[18] Roman-Blas, J.A. and Jimenez, S.A. (2006) NF-κB as a Potential Therapeutic Target in Osteorathritis and Rheumatoid Arthritis. Osteoarthritis and Cartilage, 14, 839-848. [Google Scholar] [CrossRef] [PubMed]
[19] 刘佳, 童萍, 左建平, 何东仪. LLDT-8对类风湿关节炎滑膜细胞NF-κB信号通路的影响[J]. 现代免疫学, 2018, 38(4): 265-270.
[20] Barnabei, L., Laplantine, E., Mbongo, W., Rieux-Laucat, F. and Weil, R. (2021) NF-κB: At the Borders of Autoimmunity and Inflammation. Frontiers in Immu-nology, 12, Article 716469. [Google Scholar] [CrossRef] [PubMed]
[21] 张青. NOD2参与尿酸盐晶体诱导的痛风炎症反应的机制研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2021.[CrossRef] 
[22] Mukherjee, T., Hovingh, E.S., Foerster, E.G., et al. (2019) NOD1 and NOD2 in Inflammation, Immunity and Disease. Archives of Biochemistry and Biophysics, 670, 69-81. [Google Scholar] [CrossRef] [PubMed]

为你推荐